Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1979 1
1980 4
1981 3
1982 8
1983 19
1984 10
1985 9
1986 18
1987 17
1988 27
1989 30
1990 47
1991 56
1992 81
1993 81
1994 72
1995 106
1996 139
1997 130
1998 121
1999 118
2000 123
2001 145
2002 116
2003 141
2004 122
2005 121
2006 121
2007 114
2008 111
2009 106
2010 106
2011 83
2012 94
2013 70
2014 83
2015 86
2016 74
2017 62
2018 63
2019 67
2020 74
2021 122
2022 154
2023 125
2024 88
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,437 results

Results by year

Filters applied: . Clear all
Page 1
Fluvoxamine and COVID-19.
El-Alfy AT, Busse K. El-Alfy AT, et al. WMJ. 2022;121:P2. WMJ. 2022. PMID: 35671339 Free article. No abstract available.
Fluvoxamine for the treatment of COVID-19.
Nyirenda JL, Sofroniou M, Toews I, Mikolajewska A, Lehane C, Monsef I, Abu-Taha A, Maun A, Stegemann M, Schmucker C. Nyirenda JL, et al. Cochrane Database Syst Rev. 2022 Sep 14;9(9):CD015391. doi: 10.1002/14651858.CD015391. Cochrane Database Syst Rev. 2022. PMID: 36103313 Free PMC article. Review.
Fluvoxamine has not been approved for the treatment of infections, but has been used in the early treatment of people with mild to moderate COVID-19. ...Fluvoxamine for the treatment of COVID-19 in inpatients We did not identify any completed studies of inpatients. …
Fluvoxamine has not been approved for the treatment of infections, but has been used in the early treatment of people with mild to mo …
Lack of Benefit of Fluvoxamine for COVID-19.
Bhimraj A, Gallagher JC. Bhimraj A, et al. JAMA. 2023 Jan 24;329(4):291-292. doi: 10.1001/jama.2022.23954. JAMA. 2023. PMID: 36633871 No abstract available.
Fluvoxamine for symptomatic outpatients with COVID-19.
Wu PE, Austin E, Leong D. Wu PE, et al. CMAJ. 2022 Feb 22;194(7):E258. doi: 10.1503/cmaj.220011. Epub 2022 Jan 19. CMAJ. 2022. PMID: 35045990 Free PMC article. Review. No abstract available.
Fluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetes.
Zou Y, Zhang J, Sun F, Xu Q, Chen L, Luo X, Wang T, Zhou Q, Zhang S, Xiong F, Kong W, Yang P, Yu Q, Liu S, Wang CY. Zou Y, et al. Mol Med. 2024 Feb 5;30(1):23. doi: 10.1186/s10020-024-00791-1. Mol Med. 2024. PMID: 38317106 Free PMC article.
METHOD: Herein in this report, we treated NOD mice with fluvoxamine for 2 weeks starting from 10-week of age to dissect the impact of fluvoxamine on the prevention of type 1 diabetes. ...CONCLUSION: Collectively, our study supports that fluvoxamine could be a …
METHOD: Herein in this report, we treated NOD mice with fluvoxamine for 2 weeks starting from 10-week of age to dissect the impact of …
Fluvoxamine for COVID-19?
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 May 3;63(1623):69-70. Med Lett Drugs Ther. 2021. PMID: 33976099 No abstract available.
Fluvoxamine for the treatment of COVID-19.
Dodds MG, Doyle EB, Reiersen AM, Brown F, Rayner CR. Dodds MG, et al. Lancet Glob Health. 2022 Mar;10(3):e332. doi: 10.1016/S2214-109X(22)00006-7. Lancet Glob Health. 2022. PMID: 35180412 Free PMC article. No abstract available.
Fluvoxamine for the treatment of COVID-19.
Kim H, Manzi S, Gonzelez-Heydrich J, Picker J. Kim H, et al. Lancet Glob Health. 2022 Mar;10(3):e330. doi: 10.1016/S2214-109X(22)00003-1. Lancet Glob Health. 2022. PMID: 35180410 Free PMC article. No abstract available.
Fluvoxamine for the treatment of COVID-19.
Marzolini C, Marra F, Boyle A, Khoo S, Back DJ. Marzolini C, et al. Lancet Glob Health. 2022 Mar;10(3):e331. doi: 10.1016/S2214-109X(21)00592-1. Lancet Glob Health. 2022. PMID: 35180411 Free PMC article. No abstract available.
3,437 results